Israeli company Brainsway stock is jumping 26% after FDA approves device
Company received approval for Deep-TMS as therapy to alleviate chronic depression through brain stimulation.
Brainsway stock was jumping 26 percent in mid-day trading Wednesday on triple its typical volume of trade, after the company announced American marketing approval for its brain stimulation technology to treat depression.
register with haaretz
Like us on Facebook and get articles directly in your news feed